Inicio › Cáncer de próstata › South Carolina
Ensayos clínicos de Cáncer de próstata en South Carolina
42 estudios sobre Cáncer de próstata buscan participantes en South Carolina.
Ciudades en South Carolina
- Myrtle Beach23 estudios
- Charleston15 estudios
- Greenville7 estudios
- Spartanburg5 estudios
- Greer5 estudios
- Florence3 estudios
Texto oficial del estudio (inglés)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- Self Regional Healthcare, Greenwood
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 2 oct 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- AnMed Health Cancer Center, Anderson
- Prisma Health Richland Hospital, Columbia
- McLeod Regional Medical Center, Florence
- y 12 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Gibbs Cancer Center-Gaffney, Gaffney
- Gibbs Cancer Center-Pelham, Greer
- Spartanburg Medical Center, Spartanburg
- y 1 más
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT06632977Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Medical University of South Carolina, Charleston
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT03866382Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoEstudio observacional
Edades de 40 a 75 · Hombres · Actualizado el 28 sept 2026 · NCT07543757Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Myrtle Beach
ReclutandoFase 1/2
Edades de 18 a 130 · Hombres · Actualizado el 25 sept 2026 · NCT07181161Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoFase 1/2
Edades de 18 en adelante · Hombres · Actualizado el 25 sept 2026 · NCT06800313Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 25 sept 2026 · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083), Charleston
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Grand Strand Medical Center, Myrtle Beach
- Carolina Urologic Research Center, LLC, Myrtle Beach
- Parkway Surgery Center, Myrtle Beach
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 24 sept 2026 · NCT07028853A Study in Patients With Metastatic Castration-Resistant Prostate Cancer
- START Carolinas, Myrtle Beach
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 24 sept 2026 · NCT07719361Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoFase 2/3
Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 22 sept 2026 · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- MUSC Hollings Cancer Center, Charleston
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoFase 3
Edades de 18 a 100 · Hombres · Actualizado el 22 sept 2026 · NCT06855277A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Myrtle Beach
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 18 sept 2026 · NCT06952803High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 sept 2026 · NCT05011383A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- START Carolinas, Myrtle Beach
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 15 sept 2026 · NCT07332000Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Lowcountry Urology Clinics, North Charleston
Reclutando
Edades de 18 en adelante · Hombres · Actualizado el 14 sept 2026 · NCT06511141Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 11 sept 2026 · NCT06056830Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- McLeod Regional Medical Center, Florence
- Gibbs Cancer Center-Gaffney, Gaffney
- Self Regional Healthcare, Greenwood
- y 3 más
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 10 sept 2026 · NCT05946213Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer
- Medical University of South Carolina - Hollings Cancer Center, Charleston
- Prisma Health Cancer Institute, Greenville
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 3 sept 2026 · NCT07545811A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 3 sept 2026 · NCT07005154AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Research Site, Myrtle Beach
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 26 ago 2026 · NCT07611110A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
- Ralph H. Johnson VA Medical Center, Charleston, SC, Charleston
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 25 ago 2026 · NCT05593497Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Medical University of South Carolina, Charleston
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 19 ago 2026 · NCT04423211A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 17 ago 2026 · NCT06842498Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Medical University of South Carolina, Charleston
ReclutandoFase 1
Edades de 18 a 100 · Hombres · Actualizado el 13 ago 2026 · NCT05519449Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 31 jul 2026 · NCT06613100PSMA PET Combined With MRI for the Detection of PCa
- Atlantic Urology Specialists, Myrtle Beach
ReclutandoFase 3Se aceptan voluntarios sanos
Edades de 18 en adelante · Hombres · Actualizado el 23 jul 2026 · NCT07052214Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Medical University of South Carolina, Charleston
- Levine Cancer Institute-Rock Hill, Rock Hill
ReclutandoFase 3
Edades de 18 en adelante · Hombres · Actualizado el 14 jul 2026 · NCT06592924A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Carolina Urologic Research Center, the START Center for Cancer Research, Myrtle Beach
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 9 jul 2026 · NCT07103018Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer
- South Texas Accelerated Research Therapeutics - Carolinas, Myrtle Beach
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 2 jul 2026 · NCT07140900International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Ralph H. Johnson VA Medical Center, Charleston
ReclutandoEstudio observacional
Edades de 21 en adelante · Hombres · Actualizado el 22 may 2026 · NCT03151629T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer
- Hollings Cancer Center at Medical University of South Carolina, Charleston
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 4 mar 2026 · NCT05586360Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
- Medical University of South Carolina Hollings Cancer Center, Charleston
ReclutandoFase 2
Edades de 18 en adelante · Hombres · Actualizado el 5 feb 2026 · NCT07325721A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Carolina Urologic Research Center, Myrtle Beach
ReclutandoFase 1
Edades de 18 en adelante · Hombres · Actualizado el 4 feb 2026 · NCT04729114cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- Medical University of South Carolina, Charleston
- McLeod Health, Florence
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 en adelante · Todos los sexos · Actualizado el 20 ene 2026 · NCT05366881Vitamin D for Prostate Endocrine Therapy
- Gibbs Cancer Center-Gaffney, Gaffney
- Saint Francis Hospital, Greenville
- Saint Francis Cancer Center, Greenville
- y 3 más
ReclutandoFase 3
Edades de 50 en adelante · Hombres · Actualizado el 15 ene 2026 · NCT05838716A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 123, Charleston
- Research Site 108, Greenville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 nov 2025 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Greenville
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.